Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer

Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer

The incidence of ovarian cancer, which has had a poor prognosis, is increasing annually. Currently, the prognosis is expected to improve with the use of molecular-targeted drugs and immune checkpoint inhibitors as maintenance therapies after the first-line chemotherapy. The GOG218 and ICON7 studies...

Full description

Bibliographic Details
Main Authors: Tadahiro Shoji, Chie Sato, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Medicina
Subjects:
ovarian cancer
maintenance therapy
bevacizumab
PARP inhibitor
immune checkpoint inhibitor
Online Access:https://www.mdpi.com/1648-9144/57/5/501

Internet

https://www.mdpi.com/1648-9144/57/5/501

Similar Items